21 Sep 2022 Mithra and Lotus announce approval of ALYSSA®, an innovative oral contraceptive, in both Taiwan and Hong Kong Member news
20 Sep 2022 European Medicine Agency accepts marketing authorization applications for bimekizumab in psoriatic arthritis and axial spondyloarthritis Member news
20 Sep 2022 Cellistic and Celyad Oncology announce GMP cell therapy manufacturing operations transaction Member news
12 Sep 2022 ImmuneWatch secures a VLAIO grant to tailor their technology to vaccine developers Member news
12 Sep 2022 Precirix enters into collaboration with Eckert & Ziegler for the development of its 68Ga-based compounds Member news
08 Sep 2022 Carroucell raises €1.5 million to introduce breakthrough microcarriers and customizable processes to cell and gene therapy market Member news
07 Sep 2022 New three-year BIMZELX®▼ (bimekizumab) data reinforce long-term maintenance of complete skin clearance in moderate to severe plaque psoriasis Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
